Latest News about BIIB
Recent news which mentions BIIB
From Motley Fool
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
July 31, 2023
From MarketWatch
From Benzinga
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
July 31, 2023
From Motley Fool
Could This Stock Be the Next Biotech Buyout?
July 31, 2023
From Motley Fool
From InvestorPlace
From InvestorPlace
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
July 28, 2023
From Benzinga
From Benzinga
From MarketWatch
Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?
July 28, 2023
From InvestorPlace
Biogen Bolsters Rare Disease Portfolio, Agrees To Buy Reata Pharmaceuticals With Enterprise Value Of $7.3B
July 28, 2023
From Benzinga
Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering
July 28, 2023
From MarketWatch
From Benzinga
Tickers
BIIB
From Motley Fool
Why Sage Therapeutics Stock Is Tumbling Today
July 26, 2023
From Motley Fool
From MarketWatch
From Benzinga
WMT Stock Alert: Is Walmart Really Worth $210?
July 25, 2023
From InvestorPlace
From InvestorPlace
From InvestorPlace
Biogen Q2 Earnings Tops Expectations, Shift Resources To Higher Value Area(s), Layoff 1K Staff
July 25, 2023
Tickers
BIIB
From Benzinga
Nasdaq Futures Rise Ahead Of Microsoft, Alphabet Earnings: Analyst Warns Of Volatility From Fed's Message 'Crafting'
July 25, 2023
From Benzinga
Better Big Biotech Buy: Vertex vs. Biogen
July 24, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
